Population
Patients with peripheral arterial disease (PAD) and coagulation disorders
Design
Review
Authors
Loading...
Supports individualized antithrombotic therapy in PAD coagulation disorders; leaves open optimal regimens pending prospective trials.
Management of coagulation disorders in PAD requires individualized antithrombotic therapy and a multidisciplinary approach due to weak evidence from lack of follow-up data.
Riitta Lassila (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: